SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-21-058660
Filing Date
2021-04-30
Accepted
2021-04-30 13:18:31
Documents
1
Period of Report
2021-04-16

Document Format Files

Seq Description Document Type Size
1 3 a3.html 3  
1 3 a3.xml 3 2290
  Complete submission text file 0001104659-21-058660.txt   4029
Mailing Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005
Business Address 6120 WINDWARD PARKWAY STE 290 ALPHARETTA GA 30005 678-990-5740
ALIMERA SCIENCES INC (Issuer) CIK: 0001267602 (see all company filings)

IRS No.: 200028718 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 502-1 WANT WANT PLAZA NO. 211 SHIMEN YI ROAD JING'AN DISTRICT, SHANGHAI F4 200041
Business Address 502-1 WANT WANT PLAZA NO. 211 SHIMEN YI ROAD JING'AN DISTRICT, SHANGHAI F4 200041 862161493868
Ocumension Therapeutics (Reporting) CIK: 0001840315 (see all company filings)

State of Incorp.: E9 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-34703 | Film No.: 21875856